Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

Clinical trial NCT05812404 · UNKNOWN

Trial details

NCT number: NCT05812404
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction

Start date: 2022-10-26
Primary completion: 2023-03-28
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.